纳武单抗引起的毒性表现为肺炎- 1例报告

Austin journal of pulmonary and respiratory medicine Pub Date : 2018-04-21 DOI:10.4172/2161-105X.1000455

A. Vulisha, Arunabh Talwar, S. Verma, A. Gupta, L. Lam, R. Singh, S. Bhushan

{"title":"纳武单抗引起的毒性表现为肺炎- 1例报告","authors":"A. Vulisha, Arunabh Talwar, S. Verma, A. Gupta, L. Lam, R. Singh, S. Bhushan","doi":"10.4172/2161-105X.1000455","DOIUrl":null,"url":null,"abstract":"Nivolumab is a recently approved medication that shows significant clinical activity for various types of malignancies such melanoma, renal cell carcinoma and non-small cell carcinoma. Pneumonitis is a rare, but, possibly fatal manifestation that still remains ambiguous. This article presents a case of nivolumab induced pneumonitis in a patient with melanoma and discusses management plans.","PeriodicalId":90449,"journal":{"name":"Austin journal of pulmonary and respiratory medicine","volume":"16 1","pages":"1-3"},"PeriodicalIF":0.0000,"publicationDate":"2018-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Nivolumab Induced Toxicity Presenting As Pneumonitis- A Case Report\",\"authors\":\"A. Vulisha, Arunabh Talwar, S. Verma, A. Gupta, L. Lam, R. Singh, S. Bhushan\",\"doi\":\"10.4172/2161-105X.1000455\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Nivolumab is a recently approved medication that shows significant clinical activity for various types of malignancies such melanoma, renal cell carcinoma and non-small cell carcinoma. Pneumonitis is a rare, but, possibly fatal manifestation that still remains ambiguous. This article presents a case of nivolumab induced pneumonitis in a patient with melanoma and discusses management plans.\",\"PeriodicalId\":90449,\"journal\":{\"name\":\"Austin journal of pulmonary and respiratory medicine\",\"volume\":\"16 1\",\"pages\":\"1-3\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-04-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Austin journal of pulmonary and respiratory medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4172/2161-105X.1000455\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Austin journal of pulmonary and respiratory medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2161-105X.1000455","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 1

摘要

Nivolumab是最近批准的一种药物，对各种类型的恶性肿瘤(如黑色素瘤、肾细胞癌和非小细胞癌)显示出显着的临床活性。肺炎是一种罕见的，但可能致命的表现，目前仍不清楚。本文提出了一例尼武单抗诱导的黑色素瘤患者肺炎，并讨论了管理计划。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Nivolumab Induced Toxicity Presenting As Pneumonitis- A Case Report

Nivolumab is a recently approved medication that shows significant clinical activity for various types of malignancies such melanoma, renal cell carcinoma and non-small cell carcinoma. Pneumonitis is a rare, but, possibly fatal manifestation that still remains ambiguous. This article presents a case of nivolumab induced pneumonitis in a patient with melanoma and discusses management plans.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Austin journal of pulmonary and respiratory medicine

自引率

0.00%

发文量